Enhanced Bioavailability of AC1497, a Novel Anticancer Drug Candidate, via a Self-Nanoemulsifying Drug Delivery System
AC1497 is an effective dual inhibitor of malate dehydrogenase 1 and 2 targeting cancer metabolism. However, its poor aqueous solubility results in low bioavailability, limiting its clinical development. This study was conducted to develop an effective self-nanoemulsifying drug delivery system (SNEDD...
Main Authors: | , , , , , , , |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
MDPI AG
2021-07-01
|
סדרה: | Pharmaceutics |
נושאים: | |
גישה מקוונת: | https://www.mdpi.com/1999-4923/13/8/1142 |